U.S. drug deaths plunged in 2024. Trump cuts may reverse that, experts warn.
U.S. drug deaths plunged in 2024, according to federal data published Wednesday, offering hope that public health measures are paying off even as the toll remains high.
Though there doesn't seem to be a single variable to attribute to the gains, the drop in overdose deaths comes amid concerns that cuts to federal public health agencies and proposals to cut Medicaid could undercut progress.
An estimated 80,391 people died from drugs in 2024, a decrease of nearly 27 percent from the previous year, according to provisional state data collected by the Centers for Disease Control and Prevention. Deaths from synthetic opioids — chiefly fentanyl, which has fueled the overdose crisis during the past decade — played a role in the majority of drug deaths but tumbled by nearly 28,000 fatalities, the estimates show.
The progress comes after drug deaths, which had been rising for more than a decade, soared to staggering levels during the coronavirus pandemic, surpassing 100,000 each year starting in 2021.
'I would characterize this as a historically significant decrease in overdose deaths,' said Brandon Marshall, a Brown University School of Public Health epidemiologist who studies overdose trends. 'We're really seeing decreases almost across the entire nation at this point.'
The data published Wednesday charts a dramatic decline in deaths during then-President Joe Biden's final year in office. The Trump administration has espoused hard-line rhetoric on fentanyl, declaring traffickers a top national security threat and citing them as a key reason for launching trade battles with China and allies Canada and Mexico.
The administration has also touted large fentanyl seizures and asked Mexico to allow the U.S. military to conduct counternarcotics operations on Mexican soil, a request denied by that country's president.
The CDC, in a statement, noted that Trump during his first administration declared the opioid crisis a public-health emergency in 2017. The declines since 2023 are a 'strong sign that public health interventions are making a difference and having a meaningful impact,' the agency said. 'Despite these overall improvements, overdose remains the leading cause of death for Americans aged 18-44, underscoring the need for ongoing efforts to maintain this progress.'
The White House Office of National Drug Control Policy, in an April statement of policy priorities, emphasized curbing the flow of illicit fentanyl, along with expanding access to treatment and research into cutting-edge technologies to identify and address emerging drug threats.
But public health advocates are raising alarm that the Trump administration is undercutting those goals with plans to gut federal funding that helps states pay for overdose antidotes, addiction treatment and other measures. A survey conducted by the nonprofit research firm Rand published in May suggests that more people may be using illicit opioids than previously estimated, underscoring the need for better monitoring.
In a letter to Congress on Monday, more than 300 academics warned that the Trump administration's proposed cuts to the Substance Abuse and Mental Health Services Administration and CDC could 'undermine the hard-fought progress we have made, especially in overdose prevention.'
Experts also worry Republican plans to slash Medicaid could leave former drug users without access to medication, forcing them to turn to street drugs, said Chad Sabora, a drug policy expert who helped organize the letter. 'It will equal more people dying,' he said.
The opioid crisis began decades ago with highly addictive prescription pain killers flooding states. Users later turned to cheaper street heroin, which was largely replaced by fentanyl manufactured by Mexican organized crime groups with precursor chemicals sourced from China. The synthetic drug can be up to 50 times more potent than heroin.
No single reason explains the sudden drop in deaths, researchers and health officials stress.
The Biden administration credited seizures of fentanyl at the southern border, arrests of high-level Mexican drug traffickers and cooperation from Beijing to crack down on unscrupulous Chinese companies exporting precursor chemicals. The administration also expanded access to addiction treatment medications such as buprenorphine, which wards off opioid withdrawals, and the overdose reversal drug naloxone. It also embraced harm reduction organizations that have saturated communities with free naloxone, fentanyl test strips and sterile needles to users.
Fewer deaths 'don't just happen overnight. And that's why we can credit them to the Biden administration's work,' said Sheila P. Vakharia, deputy director of research and academic engagement for the nonprofit Drug Policy Alliance.
Experts also believe that the illicit drug supply, at least in some regions, may be shifting to include less fentanyl. Other drugs added to fentanyl — such as the tranquilizer xylazine — may prolong the sedating effect and stave off opioid withdrawal so that users consume less fentanyl each day, researchers theorize.
Declines in deaths may also reflect the grim reality that fentanyl has killed so many regular users that there are fewer people at risk of overdose. The trajectory of deaths 'can't keep going up. It has essentially to kind of burn itself out,' said Caleb Banta-Green, an addiction expert and drug researcher at the University of Washington School of Medicine.
During Biden's first three years, the death toll topped 100,000 each year.
Deaths during a 12-month period peaked in June 2023 at a staggering 114,670, making the rapid drop nationally all the more remarkable, said Nabarun Dasgupta, an epidemiologist at the University of North Carolina at Chapel Hill. He stressed that deaths had been falling in certain regions where fentanyl had been entrenched for longer.
'Americans have responded to the overdose crisis with powerful community efforts, from every small town to large city. What we are seeing is the fruit of all that collective labor. These local efforts are the heart of overdose prevention,' Dasgupta said.
The CDC data released on Wednesday is not definitive; final death statistics lag because toxicology testing often takes months to complete.
Deaths involving stimulants such as methamphetamine and cocaine — which users increasingly take alongside fentanyl — also decreased, the statistics show.
Two states, Nevada and South Dakota notched slight increases from the previous year. But nearly all states showed declines in 2024. States such as New Hampshire, West Virginia and Ohio recorded declines of 35 percent or more.
In Washington state, where fentanyl became entrenched years later than on the East Coast, suspected drug deaths dropped by nearly 12 percent, after years of increases, for a total of 3,167.
In King County, home to Seattle, health officials distributed 124,700 naloxone kits in 2024 and opened three vending machines for people to obtain the medication, fentanyl test strips and other supplies. County officials and the University of Washington Department of Emergency Medicine also debuted a hotline for doctors to prescribe buprenorphine through free telehealth sessions at any time of day. The city's mayor in August announced an investment of nearly $3 million in opioid litigation settlement money to increase capacity for inpatient treatment.
But the state health department's top medical officer, Tao Kwan-Gett, urged cautioned. Washington overdose deaths fell through much of 2024 but spiked during the final four months of the year.
'It's too early to say that we're seeing a sustained decrease,' Kwan-Gett said. 'I certainly hope we are, but I think we have to continue being vigilant.'
The encouraging statistics in Washington and nationwide belie the heartbreak of addiction — and death.
Among the victims nationwide in 2024: a 17-month-old Los Angeles boy who ingested fentanyl during a child welfare-monitored visit with his mother; a 15-year-old girl who fatally overdosed on fentanyl at her Georgia high school, nine people who fatally overdosed in Austin, during one day.
In Seattle, former movie set designer Wade Paradise battled an opioid addiction for years after taking prescription pain killers. He was largely estranged from his family, living in squalor and suffering from myriad ailments, according to his daughter, Nathalie Paradise, 24.
She said Wade Paradise had struggled to get addiction treatment because of problems with health insurance. In December, he died at age 68 in his home from a pill made of fentanyl. His death received little attention but for Nathalie's GoFundMe page in which she recalled cherished childhood memories of summer swims in a lake and bargain hunting at thrift stores — and detailed his addiction.
'I didn't want it to be a secret anymore. I felt like the people in his life deserved to know the truth,' she said in an interview. 'I also have a lot of friends who use drugs, and I hoped that by sharing my story, it might encourage them to stop.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Fox News
35 minutes ago
- Fox News
Negative thoughts might be changing your brain in surprising ways, study suggests
A negative mindset is known to trigger or heighten stress and anxiety — and new research has revealed other trickle-down effects on mental and physical health. Researchers from Amen Clinics, a nationwide brain health diagnostics company, examined brain scans and cognitive data of nearly 20,000 patients who had been diagnosed with anxiety disorders. xxsaid brain disorder specialist and psychiatrist Dr. Daniel Amen, co-author of the study and founder of Amen Clinics. The people who had higher negativity bias were found to have reduced blood flow in the frontal, temporal and parietal lobes — regions critical for decision-making, memory and emotional regulation, according to Amen. "The extent of physical brain abnormalities — especially in areas not previously linked to emotional processing, like the cerebellum — was striking," he noted. These more negative people were also found to have "significantly higher levels" of depression, anxiety, suicidal ideation, emotional instability, poor memory and poor stress regulation. "Not only were mood symptoms worse, but actual thinking skills — especially memory and resilience — were compromised," Amen observed. "Until we start looking at the brain, we are flying blind in psychiatry." The findings were published in the journal Depression and Anxiety. "This research supports what I have long argued: Mental illness is brain illness," the researcher went on. "Until we start looking at the brain, we are flying blind in psychiatry." There were some limitations to note with this study, primarily its cross-sectional design, which means it captured data from a snapshot in time rather than following the group for an extended period. "The study shows association, not causation," Amen told Fox News Digital. "While negativity bias correlates with dysfunction, it doesn't definitively cause it." Based on the study findings, Amen emphasized the importance of optimizing brain health and maintaining a more positive mindset. "If you want to treat mental health seriously, you need to look at the brain," he said. "If you find yourself spiraling into negative thoughts, it may not be 'just stress'— it could be a sign that your brain needs help." Negativity bias isn't just a "bad attitude," according to Amen — "it's a neurological pattern that can spiral into full-blown cognitive and emotional breakdown." "The good news? The brain is changeable — but only if we start looking at it." While the study didn't delve into testing potential solutions, Amen noted that daily positivity practices can be beneficial. For more Health articles, visit "Broader research suggests that exercise, meditation, omega-3 consumption, gratitude journaling and deep breathing can help rewire negativity bias over time," he said.


Medscape
38 minutes ago
- Medscape
The Role of Obesity in Heart Health
Obesity is a serious, chronic condition, and in the US, more than 2 in 5 adults present with it. The disease is often linked to a host of other chronic and dangerous conditions, and according to CDC, obesity accounts for nearly $173 billion in medical expenditures. With numbers like that, it's given you will have patients in your office presenting with obesity. When that happens, one of your chief concerns and topics to address is how obesity affects your patient's heart health. 'Obesity is often called the first domino with respect to cardiometabolic health because when patients are obese, other comorbidities usually exist, such as diabetes, hypertension, sleep apnea, and metabolic disease,' said Payal Kohli, MD, founder and medical director at Cherry Creek Heart, Aurora, Colorado, and associate professor in the Division of Cardiology at Johns Hopkins University in Baltimore. 'That is why obesity can increase the risk for poor cardiovascular health through direct as well as indirect mechanisms.' Payal Kohli, MD Obesity's impact on health doesn't end there, either. According to Kohli, other complications related to the condition include elevated blood sugar, high blood pressure, inflammation and elevated sympathetic hormones. In aggregate, she said, these compromise endothelial function and result in accelerated atherosclerosis. It also affects obstructive sleep apnea and its severity, said Bradley Serwer, MD, chief medical officer at VitalSolutions. In fact, obesity is one of the main components of the dangerous condition. 'Weight loss may not fix it entirely, but it can have a positive impact,' he said. 'That's often left out of the equation when we talk about the risks of obesity.' With so many detrimental effects from the condition, finding the right approach to helping your patients with obesity is critical. Addressing the Issues At Hand There is a lot of advice you need to give to your patients with obesity, but it all begins with coaching them on lifestyle changes. Gone are the days of diets that lead to yo-yo results and in the end, might cause more harm than good. You need to have the sometimes hard conversations about weight and how to go about losing it. 'Address the issue,' said Serwer. 'Many times, PCPs [primary care physicians] don't want to address the uncomfortable topics, but you must in a diplomatic way. Urge them to consider lifestyle issues and modifications for a long-term, healthy impact.' A comprehensive approach is what's in order. This should include diet, exercise, counseling, and more. 'The cornerstones are exercise and diet, but sometimes engaging these patients is like hitting a brick wall,' said Michael Silverman, MD, a cardiologist with Johns Hopkins Medicine. 'So you have to go about it with baby steps and also figure out what's going on psychologically.' Bradley Serwer, MD This is where therapy and counseling can play a key role. There can be a host of psychological conditions beneath the condition, and it's essential to uncover them. Everything from depression and anxiety to poor home and/or work lives, to past trauma and abuse. For the PCP, it's essential to have the mental health component in mind, and a team of therapists at ready for referring your patients with obesity. One option, too, is a credible obesity clinic. These are set up with a full team ready to treat patients with obesity. From registered dieticians to counselors to physical therapists, a good obesity clinic can offer patients one-stop shopping, removing complicated barriers to accessing the many different clinicians. 'Have these resources ready to go for your obese patients,' said Serwer. 'That way they don't have to make a million different phone calls and get to numerous locations for care. It can be an incredibly valuable resource.' Even with these resources, there's still a role to play. Your counseling approach to patients with obesity needs to have sustainability in mind. 'When talking about diet, help your patients identify easy things to give up,' said Silverman. 'The first thing I'd have them get rid of is fast food — these establishments should be used for the bathroom and coffee and that's it.' Michael Silverman, MD After that, Silverman recommends patients tackle sugary drinks, juices and even diet sodas. Data backs up the fact that artificial sweeteners can trigger hunger and cravings, so address this with your patients. Beyond fast food, highly processed foods and sugary drinks, however, the approach to diet should lean toward additive versus restrictive. 'Give your patients guidance on heart healthy foods, which in turn are weight-loss friendly foods,' said Silverman. The Mediterranean Diet, for instance, is abundant in whole grains, fruits, vegetables, and healthy fats. These are all heart-healthy foods and when you coach your patients to try this eating approach, you're giving them a valuable tool for heart health. The approach also features many foods that lead to feelings of fullness, which will help stave off cravings for unhealthier options. Your patient's approach to exercise should likewise begin small and build from there. 'This can look like walking to the mailbox every day, or around the dining room table several times, as a starting point,' said Silverman. 'They can gradually increase their walking duration and eventually the intensity, and by then they should be engaged.' But expect some pushback, Silverman said. 'They will find the barriers, so you have to have answers for that,' he explains. 'If they won't walk, suggest a stationary bike. If they won't bike, try pool walking or water aerobics. There's psychiatry involved here.' Obesity Drugs and Other Tools No conversation surrounding obesity is complete today without addressing the role that GLP-1 drugs — Wegovy, Ozempic and the like — can play. 'Weight loss is instrumental in improving cardiometabolic health and it can have a tremendous impact,' said Kohli. 'Specifically, in clinical trials of the glucagon-like peptide-1 (GLP-1) or GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists weight loss was associated with an improvement in waist circumference, blood pressure, low-density lipoprotein (LDL) cholesterol, triglycerides, and a reduction in blood sugar.' Kohli said the drug class should be considered an integral part of any weight loss toolkit and admits they have become the mainstay of therapy for obesity. 'Newer evidence has shown GLP-1s improve cardiovascular outcomes as well, and reduce adverse kidney outcomes,' she adds. There are some adverse issues surrounding the weight-loss drugs that PCPs should include when counseling and potentially prescribing them to patients, however. 'They address the symptom but still don't get to the root cause of obesity,' Serwer cautions. 'And patients can lose a significant amount of weight, but much of that will come from muscle mass, so they must offset that with strength training.' Other potential pitfalls include GI distress, costs, and potential drug shortages. The drugs can sometimes cause food aversions, too, which isn't helpful when patients are trying to eat better, more nutrient dense diets. 'The biggest problem is that they don't address lifestyle changes,' said Serwer. 'If we don't address that, the weight will eventually come back.' The best news is that with patients with obesity, even small weight loss can have big impact on cardiovascular health. Said Silverman: 'When the weight comes off, patients may be able to go off most of their medications, and that's a huge benefit.'


New York Times
39 minutes ago
- New York Times
In Some Ozempic Households, the Weight Loss is Contagious
When Amy Kane started taking Mounjaro in 2022, she expected to lose weight — which she did, dropping more than 170 pounds. What Ms. Kane, a 36-year-old content creator in Chicago, didn't expect was for the effects on her health to be contagious. Soon after she started the medication, her husband and children began eating more healthfully — and then became more physically active, too. As medications like Ozempic transform the health of millions of Americans, some families are discovering a surprising side effect: family members who are not taking the drugs are changing their relationship with food and in some cases, losing weight as well. There isn't data yet to show how frequently this might occur, but medical experts have long observed similar effects with other weight-loss treatments, said Dr. Lydia Alexander, the former president of the Obesity Medicine Association. One study of bariatric surgery patients found that two-thirds of partners lost weight within a year of their spouse's operation, with overweight partners showing the most significant changes. Another study of participants with diabetes in a weight loss program found that spouses who weren't undergoing any treatment lost an average of nearly five pounds and consumed significantly fewer calories from fat. And anecdotally, providers around the country said they are already seeing a similar effect with the families of patients taking drugs like Ozempic. 'These medications don't just change appetite, they transform family dynamics,' said Dr. Joey Skelton, professor of pediatrics at Wake Forest University School of Medicine. By 2024, about one in eight U.S. adults had taken Ozempic or a similar drug, meaning tens of millions of spouses, children and other family members could also be experiencing some effect from these medications without ever taking them. Want all of The Times? Subscribe.